Terms: = Head and neck cancer AND SRGAP3, MEGAP, 9901, ENSG00000196220, ARHGAP14, KIAA0411, WRP AND Treatment
6 results:
1. A multicenter, phase 3, randomized trial of concurrent chemoradiotherapy plus adjuvant chemotherapy versus radiotherapy alone in patients with regionally advanced nasopharyngeal carcinoma: 10-year outcomes for efficacy and toxicity.
Lee AWM; Tung SY; Ng WT; Lee V; Ngan RKC; Choi HCW; Chan LLK; Siu LL; Ng AWY; Leung TW; Yiu HHY; O'Sullivan B; Chappell R
Cancer; 2017 Nov; 123(21):4147-4157. PubMed ID: 28662313
[TBL] [Abstract] [Full Text] [Related]
2. Surgery alone versus chemoradiotherapy followed by surgery for stage I and II esophageal cancer: final analysis of randomized controlled phase III trial FFCD 9901.
Mariette C; Dahan L; Mornex F; Maillard E; Thomas PA; Meunier B; Boige V; Pezet D; Robb WB; Le Brun-Ly V; Bosset JF; Mabrut JY; Triboulet JP; Bedenne L; Seitz JF
J Clin Oncol; 2014 Aug; 32(23):2416-22. PubMed ID: 24982463
[TBL] [Abstract] [Full Text] [Related]
3. The impact of concurrent granulocyte-macrophage colony-stimulating factor on quality of life in head and neck cancer patients: results of the randomized, placebo-controlled Radiation Therapy Oncology Group 9901 trial.
Hoffman KE; Pugh SL; James JL; Scarantino C; Movsas B; Valicenti RK; Fortin A; Pollock J; Kim H; Brachman DG; Berk LB; Bruner DW; Kachnic LA
Qual Life Res; 2014 Aug; 23(6):1841-58. PubMed ID: 24492945
[TBL] [Abstract] [Full Text] [Related]
4. Evidence based and new developments in re-irradiation for recurrent or second primary head and neck cancers.
Mouttet-Audouard R; Gras L; Comet B; Lartigau E
Curr Opin Otolaryngol Head Neck Surg; 2012 Apr; 20(2):137-41. PubMed ID: 22249172
[TBL] [Abstract] [Full Text] [Related]
5. [Reirradiation for recurrent or second primary head and neck cancers].
Mouttet-Audouard R; Gras L; Comet B; Lartigau E
Bull Cancer; 2011 Dec; 98(12):1477-88. PubMed ID: 22157636
[TBL] [Abstract] [Full Text] [Related]
6. Factors contributing to the efficacy of concurrent-adjuvant chemotherapy for locoregionally advanced nasopharyngeal carcinoma: combined analyses of NPC-9901 and NPC-9902 Trials.
Lee AW; Tung SY; Ngan RK; Chappell R; Chua DT; Lu TX; Siu L; Tan T; Chan LK; Ng WT; Leung TW; Fu YT; Au GK; Zhao C; O'Sullivan B; Tan EH; Lau WH
Eur J Cancer; 2011 Mar; 47(5):656-66. PubMed ID: 21112774
[TBL] [Abstract] [Full Text] [Related]
